bannerInternoIvirma2

industry-sponsored symposium

 
  • 16.30-17.30h
    • Management of Poor Responders: Exploring Therapeutic Considerations
      Chairman:
      Dr. Gaurang Daftary
      Global Scientific Vice President, RMMH, Ferring Pharmaceuticals 
    • The Poor Responder: Evolving our understanding
      Dr. Christine Wyns
      Head of the Cliniques Universitaires Saint-Luc's Gynaecology and Andrology Department
      Medical Director of the Reproductive Tissue and Cell Bank.
      Professor at Université Catholique de Louvain. 
    • The Poor Responder: Protocol considerations
      Dr. Juan Antonio García Velasco
      Director of IVI Madrid.
      Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid, Spain. 
    • The Poor Responder: Clinical Practice
      Drs. Wyns & García Velasco

    CHECH THE PROGRAM
    17.30-18.30h

    The era of individual luteal phase support (iLPS) has begun
    Chairman:
    Joaquín Llácer
    Medical Director Ginefiv-GeneraLife Spain
    • Importance of progesterone levels during implantation
      Dominique De Ziegler
      University Consultant at Foch Hospital, France
    • Beyond implantation. Progesterone levels for maintenance of pregancy
      Elena Labarta
      Gynaecologist specialized in assisted reproduction. IVIRMA, Spain

    CHECH THE PROGRAM
    18.30-19.30h

    • Personalized Management of patients in reproductive medicine
      Moderator:
      Monica Lispi
      GMA Merck 
    • Speaking about success in Normoresponders
      Dr. Filippo Ubaldi 
    • Who may benefit of rLH?
      Dr. Shahar Kol

    CHECH THE PROGRAM
  • 16.30-17.30h
    • How Artificial Intelligence could improve IVF utilizationWelcome
      Chairman:
      Nick Macklon 
    • Overview of artificial Intelligence in Healthcare
      Ignacio H. Medrano
      Founder & Chief Medical Officer at SAVANA 
    • Clinical integration into IVF of Artificial Intelligence and Machine learning
      Ernesto Bosch
      Medical Director IVIRMA Valencia 
    • Conclusions
      Chairman
      Nick Macklon

    CHECH THE PROGRAM
    17.30-18.30h

    • Organon Introduction (10’)
      Keith Gordon
      Executive Global Director of Fertility Medical affairs in Organon (Chairman) 
    • Customizing the approach of ovarian stimulation for every patient category
      Christophe Blockeel
      Medical Director Centre for Reproductive Medicine, UZ Brussel 
    • Q&A (10’-15’)

    CHECH THE PROGRAM
    18.30-19.30h



    Why an electronic witnessing system is valued as an essential team player by both clinics and patients
    Moderator: Karen Schnauffer 

    • The Lab Managers perspective on why RI Witness should be considered a “team player” in the lab
      Albert Obradors
      Founder and Lab Director
      FIV Obradors
    • The patient perspective on the benefits of an electronic witnessing system
      Stephen Troup
      Consultant Reproductive Scientist

    CHECH THE PROGRAM